Like PO3, these large investors paying premium and buying their board seat are usually a sign that there is plenty upside to follow. I see from PBT's website that they are leveraging the anti-aging market to the max.
Believe in it or not, it is very big business. But on that note, the 'quality of ageing life' is a more appropriate description. I note there work in epigenetics. This is where AIY has also entered with their buying into Aenea.
Like PO3, these large investors paying premium and buying their...
Add XAO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8,699.1 |
Change
-0.900(0.01%) |
Mkt cap ! n/a | |||
| Open | High | Low |
| 8,700.0 | 8,700.0 | 8,649.0 |
| XAO (ASX) Chart |
